positions available now

Commercial Eyes appoints Simon Higgins to head up new Commercialisation Services division

Commercial Eyes Pty. Ltd., one of Australia’s most successful health technology commercialisation companies, is pleased to announce the appointment of Simon Higgins to head up it’s new Commercialisation Services division.

Simon joins Commercial Eyes with over 20 years’ experience in the healthcare industry most notably as Director of Business Operations and the Commercial Lead for Pfizer, and more recently as heading up Bristol Myers Squibb’s Access, Policy and Advocacy division.

The new Commercialisation Services division offers a comprehensive and focused range of consulting services across the company’s existing offering of Market Insights, Market Access, Pricing and Policy as well as Medical Communications and Patient Engagement. It will also complement the company’s Medical Services division.

“In an increasingly complex environment we continue to see a need to provide integrated and comprehensive commercialisation services that allow medicines and other treatments to get to patients as quickly as possible,” Commercial Eyes’ founder and Managing Director, Andrew Carter said.

We saw Simon’s background and experience as the perfect fit for this role which draws on his broad experience in market access and commercialisation of novel pharmaceuticals and in the growth of established technologies.

Established in 2001, Commercial Eyes has rapidly grown to become a leading pharmaceutical and medical device commercialisation business with almost 90 people across four countries. Comprised of experienced subject matter experts with substantial real-world experience and a pragmatic, solutions-oriented approach, the company delivers tailored advice and services to those with a commercial interest in getting medicines to market.

On his appointment, Simon commented, “What has impressed me most is the passion the Commercial Eyes team has in partnering with our clients to get their health technology to patients that can benefit. This is across an incredibly broad offering, including understanding the local market dynamics, navigating the most appropriate regulatory and reimbursement pathway, communicating the value and benefits of product innovation, through to assisting sponsors to meet their post market safety requirements.

“Commercial Eyes is also setting a high standard in the industry with its workplace culture. While they have a commitment to delivery high-quality outcomes, this is achieved in a co-operative and supportive environment. There is a strong focus on community engagement, flexibility and wellbeing in the workplace which really appeals to me.”

I am looking forward to working together with the Commercial Eyes team and our clients to fulfil their objectives within the Australian and New Zealand health systems, leveraging the expertise from right across the Commercial Eyes business.

This entry was posted in Commercial Eyes, Commercialisation Services, Market Access, Market Insight, Medical Communications, Medical Services, Regulatory Services and tagged , , , , .
Copyright © 2020 Commercial Eyes